The role of cardiovascular MRI in heart failure and the cardiomyopathies.

[1]  H. Calkins,et al.  Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. , 2006, Journal of the American College of Cardiology.

[2]  D. Pennell,et al.  Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.

[3]  Maria Drangova,et al.  Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. , 2006, Journal of the American College of Cardiology.

[4]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[5]  R. Cury,et al.  Delayed contrast enhancement CMR imaging in apical hypertrophic cardiomyopathy. , 2006, International journal of cardiology.

[6]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[7]  S. Brodie,et al.  Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement , 2006, Genetics in Medicine.

[8]  R. Schiffmann,et al.  Enzyme-Replacement Therapy With Agalsidase Alfa in Children With Fabry Disease , 2006, Pediatrics.

[9]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[10]  R. Cury,et al.  Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. , 2006, Radiology.

[11]  A. Tajik,et al.  Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Jeroen J. Bax,et al.  Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue doppler imaging and velocity-encoded magnetic resonance imaging. , 2006, Journal of the American College of Cardiology.

[13]  H. Ju,et al.  Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. , 2006, The American journal of cardiology.

[14]  J. Foster,et al.  Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. , 2006, Kidney international.

[15]  L. Monserrat,et al.  Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy: Relationship with Left Ventricular Perfusion and Contractile Function , 2006, Journal of computer assisted tomography.

[16]  C. Gaudio,et al.  Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. , 2006, Journal of the American College of Cardiology.

[17]  Igor Klem,et al.  mproved Detection of Coronary rtery Disease by Stress Perfusion ardiovascular Magnetic Resonance With he Use of Delayed Enhancement Infarction Imaging , 2006 .

[18]  B. Maisch,et al.  Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. , 2006, International journal of cardiology.

[19]  Y. Jang,et al.  Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction. , 2006, Journal of cardiac failure.

[20]  Jeroen J. Bax,et al.  Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy , 2006, Circulation.

[21]  Filippo Cademartiri,et al.  Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. , 2006, Journal of the American College of Cardiology.

[22]  F. Salvi,et al.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance , 2005, Heart.

[23]  D. Pennell,et al.  Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[24]  M. Sheppard,et al.  The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[25]  Marco Francone,et al.  Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy , 2006, European Radiology.

[26]  Theodore P Abraham,et al.  Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts. , 2005, Journal of the American College of Cardiology.

[27]  Robert G. Weiss,et al.  Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.

[28]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[29]  Fabien Hyafil,et al.  Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. , 2005, Radiology.

[30]  R. Falk.  Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[31]  N. Villari,et al.  Detection and assessment of coronary artery anomalies by three-dimensional magnetic resonance coronary angiography. , 2005, International journal of cardiology.

[32]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[33]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[34]  D. Pennell,et al.  Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I , 2005, Heart.

[35]  Stefan Neubauer,et al.  Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[36]  S. Kanao,et al.  Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. , 2005, AJR. American journal of roentgenology.

[37]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[38]  W. Dassen,et al.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.

[39]  M. Götte,et al.  Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy , 2005, Circulation.

[40]  Raymond J Kim,et al.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. , 2005, Journal of the American College of Cardiology.

[41]  R. Hershberger,et al.  Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[42]  F. Ridocci,et al.  Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.

[43]  I. Kholová,et al.  Amyloid in the cardiovascular system: a review , 2005, Journal of Clinical Pathology.

[44]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[45]  Hugh Calkins,et al.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[46]  K. Teraoka.  Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. , 2004, Magnetic resonance imaging.

[47]  Y. Ikari,et al.  Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. , 2005, Kidney international.

[48]  D. Pennell,et al.  Cardiovascular magnetic resonance in endocardial fibroelastosis. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[49]  S. Plein,et al.  Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[50]  Warren J Manning,et al.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[51]  D. Pennell,et al.  Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance , 2004, British journal of haematology.

[52]  Y. Amano,et al.  Delayed hyper‐enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: Comparison with global and regional cardiac MR imaging appearances , 2004, Journal of magnetic resonance imaging : JMRI.

[53]  Lisa Hartling,et al.  Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.

[54]  E. Fleck,et al.  Comparison of Dobutamine Stress Magnetic Resonance, Adenosine Stress Magnetic Resonance, and Adenosine Stress Magnetic Resonance Perfusion , 2004, Circulation.

[55]  D A Bluemke,et al.  Myocardial First-Pass Perfusion Magnetic Resonance Imaging: A Multicenter Dose-Ranging Study , 2004, Circulation.

[56]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[57]  D. Pennell,et al.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[58]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[59]  Edward Kasper,et al.  Misdiagnosis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Journal of cardiovascular electrophysiology.

[60]  A. van Rossum,et al.  Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[61]  N. Samani,et al.  Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach , 2002, The International Journal of Cardiovascular Imaging.

[62]  Stephan Achenbach,et al.  Clinical utility of computed tomography and magnetic resonance techniques for noninvasive coronary angiography. , 2003, Journal of the American College of Cardiology.

[63]  D. Pennell,et al.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.

[64]  Dipan J. Shah,et al.  Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.

[65]  K. Takeda,et al.  Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. , 2003, Radiology.

[66]  Richard D. White,et al.  Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. , 2003, American heart journal.

[67]  B. Giorgi,et al.  Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. , 2003, Radiology.

[68]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[69]  D. Pennell,et al.  A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.

[70]  H. Eiskjaer,et al.  Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. , 2003, Blood.

[71]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[72]  H. Calkins,et al.  Magnetic Resonance Imaging Findings in Patients Meeting Task Force Criteria for Arrhythmogenic Right Ventricular Dysplasia , 2003, Journal of cardiovascular electrophysiology.

[73]  Jennifer Keegan,et al.  Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. , 2003, Radiology.

[74]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[75]  S. Dymarkowski,et al.  Visualization of Ventricular Thrombi With Contrast-Enhanced Magnetic Resonance Imaging in Patients With Ischemic Heart Disease , 2002, Circulation.

[76]  B. Iung,et al.  MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. , 2002, Chest.

[77]  P. Elliott,et al.  Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy , 2002, Circulation.

[78]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[79]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[80]  H. Wen,et al.  Mixed echo train acquisition displacement encoding with stimulated echoes: An optimized DENSE method for in vivo functional imaging of the human heart , 2001, Magnetic resonance in medicine.

[81]  J. Berlin,et al.  Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. , 2001, American heart journal.

[82]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[83]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[84]  P. Kaufmann,et al.  Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. , 2000, Journal of the American College of Cardiology.

[85]  Colin Baigent,et al.  Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.

[86]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[87]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[88]  M. Piette,et al.  Endocardial fibroelastosis as a cause of sudden unexpected death. , 1999, The American journal of forensic medicine and pathology.

[89]  T. Michele,et al.  The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. , 1999, Medicine.

[90]  M. Cappellini,et al.  Survival and Disease Complications in Thalassemia Major , 1998, Annals of the New York Academy of Sciences.

[91]  O Strohm,et al.  Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.

[92]  J. Ramires,et al.  Magnetic Resonance Imaging in Chronic Chagas' Disease , 1998, Echocardiography.

[93]  R. Falk,et al.  The systemic amyloidoses. , 1997, The New England journal of medicine.

[94]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[95]  M. Ritter,et al.  Isolated noncompaction of the myocardium in adults. , 1997, Mayo Clinic proceedings.

[96]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[97]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[98]  H. Tazelaar,et al.  Racial difference in cardiac sarcoidosis incidence observed at autopsy. , 1994, Sarcoidosis.

[99]  G. Breithardt,et al.  Arrhythmogenic right ventricular disease: MR imaging vs angiography. , 1993, AJR. American journal of roentgenology.

[100]  A. Movahed,et al.  Sarcoidosis of the Heart , 1993, Clinical cardiology.

[101]  C. Higgins,et al.  Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. , 1992, Radiology.

[102]  A. Hoffbrand,et al.  High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. , 1990, Acta haematologica.

[103]  E. Ritz,et al.  Diffuse intermyocardiocytic fibrosis in uraemic patients. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[104]  R. Rowe,et al.  Natural history and prognostic risk factors in endocardial fibroelastosis. , 1988, The American journal of cardiology.

[105]  A. Tajik,et al.  Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. , 1988, Archives of internal medicine.

[106]  B. Gersh,et al.  Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. , 1987, Journal of the American College of Cardiology.

[107]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[108]  P. Rahko,et al.  Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. , 1986, Journal of the American College of Cardiology.

[109]  R. Virmani,et al.  Cardiac sarcoidosis; a major cause of sudden death in young individuals. , 1980, Chest.

[110]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[111]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.

[112]  W. Roberts,et al.  Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II) , 1977 .

[113]  B. Schreiner,et al.  Reversible cardiomyopathy associated with hemochromatosis. , 1972, The New England journal of medicine.